Cisplatin-Radiation Interactions in Tumours and Normal Tissues

[1]  A. Begg.  Additivity versus repair inhibition in fractionated treatments combining drugs and X rays: a theoretical analysis. , 1987, International journal of radiation oncology, biology, physics.

[2]  F. Stewart,et al.  Tolerance of previously irradiated mouse kidneys to cis-diamminedichloroplatinum(II). , 1987, Cancer research.

[3]  H. Bartelink,et al.  Radiosensitization by cisplatin of RIF1 tumour cells in vitro. , 1986, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[4]  H. Bartelink,et al.  Renal damage in mice after treatment with cisplatinum alone or in combination with X-irradiation. , 1986, International journal of radiation oncology, biology, physics.

[5]  H. Bartelink,et al.  Influence of cis-diamminedichloroplatinum (II) on mouse duodenal crypt stem cell survival after multifraction X ray treatment. , 1985, International journal of radiation oncology, biology, physics.

[6]  J. Gray,et al.  A new mouse tumor model system (RIF-1) for comparison of end-point studies. , 1980, Journal of the National Cancer Institute.

[7]  H. Bartelink,et al.  Early and late damage in the mouse rectum after irradiation andcis-diamminedichloroplatinum(II) , 1987 .

[8]  H. Withers,et al.  Microcolony survival assay for cells of mouse intestinal mucosa exposed to radiation. , 1970, International journal of radiation biology and related studies in physics, chemistry, and medicine.